Imunon, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on June 16, 2026, specifically the 2026 Annual Meeting of Stockholders for Imunon, Inc. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol IMNN.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and shareholder voting outcomes rather than financial performance data.
Material Changes and Voting Results
At the Annual Meeting, 1,808,666 shares were represented, constituting a quorum out of 3,983,342 outstanding shares. Key actions included:
- Director Elections: Stockholders elected Frederick J. Fritz and Christine A. Pellizzari as Class I directors. Dr. Stacy R. Lindborg, Mr. Michael H. Tardugno, Mr. James E. Dentzer, and Dr. Donald P. Braun continued their service.
- Stock Incentive Plan Amendment: Shareholders approved an amendment to the 2018 Stock Incentive Plan, increasing the aggregate share limit by 1,000,000 shares to a new total of 1,265,004 shares.
- Accounting Firm Ratification: WithumSmith + Brown, PC was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Executive Compensation: The advisory "Say-on-Pay" proposal for 2025 named executive officer compensation was approved.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the results of the shareholder vote and the amendment to the stock incentive plan.
Investor Verification Checklist
- Verify the impact of the 1,000,000 share increase in the Stock Incentive Plan on potential future dilution.
- Review the full text of the amended 2018 Stock Incentive Plan (Exhibit 10.1) for specific award terms.
- Confirm the tenure and responsibilities of the newly elected directors, Fritz and Pellizzari.
- Check the Definitive Proxy Statement filed on May 4, 2026, for detailed rationale behind the Say-on-Pay vote and director nominations.